Log in to save to my catalogue

A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapit...

A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapit...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7de97dc48ab74877a0bff6bbe23063ab

A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses

About this item

Full title

A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses

Publisher

England: The Company of Biologists Ltd

Journal title

Disease models & mechanisms, 2016-09, Vol.9 (9), p.927-939

Language

English

Formats

Publication information

Publisher

England: The Company of Biologists Ltd

More information

Scope and Contents

Contents

Although β-blockers can be used to eliminate stress-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), this treatment is unsuccessful in ∼25% of cases. Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) generated from these patients have potential for use in investigating the...

Alternative Titles

Full title

A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7de97dc48ab74877a0bff6bbe23063ab

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7de97dc48ab74877a0bff6bbe23063ab

Other Identifiers

ISSN

1754-8403

E-ISSN

1754-8411

DOI

10.1242/dmm.026823

How to access this item